1. Home
  2. VRNA vs MCY Comparison

VRNA vs MCY Comparison

Compare VRNA & MCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • MCY
  • Stock Information
  • Founded
  • VRNA 2005
  • MCY 1961
  • Country
  • VRNA United Kingdom
  • MCY United States
  • Employees
  • VRNA N/A
  • MCY N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • MCY Property-Casualty Insurers
  • Sector
  • VRNA Health Care
  • MCY Finance
  • Exchange
  • VRNA Nasdaq
  • MCY Nasdaq
  • Market Cap
  • VRNA 3.4B
  • MCY 3.7B
  • IPO Year
  • VRNA 2017
  • MCY N/A
  • Fundamental
  • Price
  • VRNA $67.96
  • MCY $52.25
  • Analyst Decision
  • VRNA Strong Buy
  • MCY Strong Buy
  • Analyst Count
  • VRNA 7
  • MCY 1
  • Target Price
  • VRNA $57.14
  • MCY $80.00
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • MCY 951.7K
  • Earning Date
  • VRNA 02-27-2025
  • MCY 02-11-2025
  • Dividend Yield
  • VRNA N/A
  • MCY 2.43%
  • EPS Growth
  • VRNA N/A
  • MCY 385.68
  • EPS
  • VRNA N/A
  • MCY 8.45
  • Revenue
  • VRNA $5,624,000.00
  • MCY $5,475,633,000.00
  • Revenue This Year
  • VRNA N/A
  • MCY N/A
  • Revenue Next Year
  • VRNA $571.44
  • MCY $7.13
  • P/E Ratio
  • VRNA N/A
  • MCY $6.19
  • Revenue Growth
  • VRNA 1127.95
  • MCY 18.27
  • 52 Week Low
  • VRNA $11.39
  • MCY $44.19
  • 52 Week High
  • VRNA $68.64
  • MCY $80.72
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 76.88
  • MCY 46.18
  • Support Level
  • VRNA $62.24
  • MCY $50.27
  • Resistance Level
  • VRNA $65.50
  • MCY $62.84
  • Average True Range (ATR)
  • VRNA 2.78
  • MCY 2.69
  • MACD
  • VRNA 0.22
  • MCY 0.74
  • Stochastic Oscillator
  • VRNA 94.86
  • MCY 28.01

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The Company offers the following types of automobile coverage: collision, property damage, bodily injury ("BI"), comprehensive, personal injury protection ("PIP"), underinsured and uninsured motorist, and other hazards. The Company offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages.

Share on Social Networks: